Needham Upgrades Rocket Pharmaceuticals to Buy from Hold
Published . Updated .
Fintel reports that on September 16, 2026, Needham upgraded their outlook for Rocket Pharmaceuticals (NASDAQGM:RCKT) from Hold to Buy.Rocket Pharmaceuticals, Inc., headquartered in the United States, is at the forefront of the biotechnological industry, specializing in the develo
Directly affected
- RCKT Rocket Pharmaceuticals
Named in this report.
- RCKTW ROCKET PHARMACEUTICALS INC
The reported development directly names ROCKET PHARMACEUTICALS INC in the headline; GA resolved that company to RCKTW.
Indirectly affected
- XPH STATE STREET SPDR S&P PHARMACEUTICALS ETF
GA selected XPH as a RELATED security because its canonical security name directly matches this event's themes: pharmaceuticals. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
Price reaction, T-5 to T+3
Fintel reports that on September 16, 2026, Needham upgraded their outlook for Rocket Pharmaceuticals (NASDAQGM:RCKT) from Hold to Buy.Rocket Pharmaceuticals, Inc., headquartered in the United States, is at the forefront of the biotechnolog…
Source: Nasdaq Markets
How far Rocket Pharmaceuticals (RCKTW) has moved since 17 Sep 2026
Who is named in “Needham Upgrades Rocket Pharmaceuticals to Buy from Hold”
Companies carried with this story
- RCKTW Rocket Pharmaceuticals
Rocket Pharmaceuticals (RCKTW) is linked, with no stored direction, high confidence in the 17 Sep 2026 story “Needham Upgrades Rocket Pharmaceuticals to Buy from Hold.” Reason on file: The reported development directly names ROCKET PHARMACEUTICALS INC in the headline; GA resolved that company to RCKTW
- XPH State Street Spdr S&P Pharmaceuticals Etf
For “Needham Upgrades Rocket Pharmaceuticals to Buy from Hold,” State Street Spdr S&P Pharmaceuticals Etf (XPH) is linked, with no stored direction, medium confidence. Reason on file: GA selected XPH as a RELATED security because its canonical security name directly matches this event's themes: pharmaceuticals. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- RCKT Rocket Pharmaceuticals
In “Needham Upgrades Rocket Pharmaceuticals to Buy from Hold,” Rocket Pharmaceuticals (RCKT) is linked, with no stored direction, medium confidence. Reason on file: GA selected RCKT as a RELATED security because its canonical security name directly matches this event's themes: pharmaceuticals, rocket. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
How “Needham Upgrades Rocket Pharmaceuticals to Buy from Hold” reaches Rocket Pharmaceuticals (RCKTW)
“Needham Upgrades Rocket Pharmaceuticals to Buy from Hold” (17 Sep 2026) reaches Rocket Pharmaceuticals (RCKTW) through this story.
What ties Rocket Pharmaceuticals (RCKTW) to the headline is this: The reported development directly names ROCKET PHARMACEUTICALS INC in the headline; GA resolved that company to RCKTW
A second company, State Street Spdr S&P Pharmaceuticals Etf (XPH), is listed for a different reason: GA selected XPH as a RELATED security because its canonical security name directly matches this event's themes: pharmaceuticals. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
The price range for Rocket Pharmaceuticals (RCKTW), and the dates in the story
RCKT traded between 2.17 and 3.40 across 20 sessions. The latest close on file is 2.23. XPH traded between 61.54 and 68.95 across 20 sessions. The latest close on file is 62.24.
What the saved facts support for Rocket Pharmaceuticals (RCKTW)
27 out of 100
“Needham Upgrades Rocket Pharmaceuticals to Buy from Hold” scores 27 out of 100. The score uses 1 sources, and 3 linked companies.